Augmentation of high molecular weight kininogen and reduction of kallikrein activity in plasma of L-NAME hypertensive rats.

被引：0

作者：

Sendäo, AP ^{[1
]}

Poggi, JC ^{[1
]}

Bendhack, LM ^{[1
]}

Reis, ML ^{[1
]}

机构：

[1] Univ Sao Paulo, Coll Pharmaceut Sci Ribeirao Preto, Pharmacol Lab, BR-14040903 Ribeirao Preto, SP, Brazil

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

P1515

引用

页码：R337 / R337

页数：1

共 50 条

[21] HIGH MOLECULAR-WEIGHT KININOGEN - ITS INABILITY TO CORRECT THE CLOTTING OF KININOGEN-DEFICIENT PLASMA AFTER CLEAVAGE OF BRADYKININ BY PLASMA KALLIKREIN, PLASMIN OR TRYPSIN [J].

CHAN, JYC ;

MOVAT, HZ ;

BURROWES, CE .

THROMBOSIS RESEARCH, 1979, 14 (06) :817-824

[22] REDUCED COFACTOR FUNCTION OF HUMAN HIGH MOLECULAR-WEIGHT KININOGEN INDUCED BY HUMAN-PLASMA KALLIKREIN [J].

THIDEMANN, H ;

BRISEID, K .

ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1984, 55 (01) :25-32

[23] Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat [J].

A. M. Rothschild ;

Eleni L. T. Gomes ;

Ivanilda C. Fortunato .

Naunyn-Schmiedeberg's Archives of Pharmacology, 1998, 358 :483-488

[24] Bradykinin release from high molecular weight kininogen and increase in plasma kallikrein-like activity following sensory stimulation by food in the rat [J].

Rothschild, AM ;

Gomes, ELT ;

Fortunato, IC .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (04) :483-488

[25] HUMAN HIGH MOLECULAR-WEIGHT KININOGEN - EFFECTS OF CLEAVAGE BY KALLIKREIN ON PROTEIN-STRUCTURE AND PROCOAGULANT ACTIVITY [J].

SCHIFFMAN, S ;

MANNHALTER, C ;

TYNER, KD .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (13) :6433-6438

[26] SURFACE-INDUCED ALTERATIONS IN THE KINETIC PATHWAY FOR CLEAVAGE OF HUMAN HIGH-MOLECULAR-WEIGHT KININOGEN BY PLASMA KALLIKREIN [J].

TAYEH, MA ;

OLSON, ST ;

SHORE, JD .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (23) :16318-16325

[27] HIGH MOLECULAR-WEIGHT KININOGEN PROTECTS HUMAN-PLASMA KALLIKREIN AGAINST INACTIVATION BY CL-INHIBITOR [J].

SCHAPIRA, M ;

SCOTT, C ;

BACON, R ;

COLMAN, RW .

CLINICAL RESEARCH, 1980, 28 (02) :A497-A497

[28] ISOLATION OF A CATIONIC FRAGMENT OF HIGH MOLECULAR MASS KININOGEN AND EFFECT OF THIS FRAGMENT ON HUMAN-PLASMA KALLIKREIN ACTIVITY [J].

YAROVAYA, GA ;

DOTSENKO, VL ;

OREKHOVICH, VN .

CLINICA CHIMICA ACTA, 1982, 123 (03) :261-267

[29] CHANGES IN PLASMA-LEVELS OF PREKALLIKREIN, KALLIKREIN, HIGH MOLECULAR-WEIGHT KININOGEN AND KALLIKREIN INHIBITORS DURING LETHAL ENDOTOXIN-SHOCK IN DOGS [J].

GALLIMORE, MJ ;

AASEN, AO ;

AMUNDSEN, E .

HAEMOSTASIS, 1978, 7 (2-3) :79-84

[30] AT1 receptor antisense gene therapy prevents the development of high blood pressure in L-NAME treated rats. [J].

Reaves, PY ;

Francis, SC ;

Beck, CR ;

Katovich, MJ ;

Raizada, MK .

HYPERTENSION, 2001, 38 (03) :495-495

← 1 2 3 4 5 →